At the 22 May VRBPAC meeting, the FDA declined to discuss how its new COVID-19 vaccine framework could impact strain changes for 2025-2026 shots. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
